This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International
September 16-18, 2025
Hynes Convention CenterBoston, MA
Register for Passes Today
Menu
Book Now
Key Sessions
Kristy Wood
Leveraging Gene Editing Technologies for Precision and Efficiency in Cell and Gene Therapy Development
Intellia Therapeutics
Ying Cai
Keynote Panel Discussion: Strategies for Scaling Up, Accelerating and Commercializing Gene Therapy Manufacturing
Ultragenyx Pharmaceutical
keyboard_arrow_right

Wednesday, September 17th, 2025 - Main Conference Day One - ET (Eastern Time, GMT-05:00)

keyboard_arrow_leftSearch & Filter
search
Wednesday, September 17th, 2025 - Main Conference Day One - ET (Eastern Time, GMT-05:00)
search
Showing 1 of 1 Streams
8:50am - 9:00am
Chairperson’s Opening Remarks: Cell Therapy Manufacturing & Analytics
  • Mahesh Bule - Associate Director, Kite Pharma a Gilead Company
9:00am - 9:30am
Scale-Out Versus Scale-up Strategies for Maximizing Cellular Therapies
  • Amy Shaw - Head of Process and Product Development, Takeda, USA
9:30am - 10:00am
TCR-T: Scaling for Success
  • Mark Farmery - Chief Development Officer, Anocca AB
10:00am - 10:30am
Panel Discussion: Bringing Cell Therapy to the Patient—Implementing Decentralized Manufacturing
  • Francesca Vitelli, PhD - VP Global head of Process and Analytical Development and Innovation (PADI), Minaris
  • Spencer Hoover - Principal Consultant, SH Consulting LLC
  • Therese Choquette - Head of Analytical and Translational Sciences, Tigen Pharma
Showing 1 of 1 Streams
11:30am - 12:00pm
Revolutionizing Cell Therapy with Automated Manufacturing and Testing Solutions
  • Shawn (Xueyuan) Wang - Director, Process Development, Kite Pharma
12:00pm - 12:30pm
Scalable and Cost-Effective Pluripotent Stem Cell Expansion: Enabling Commercialization
  • Wonjong Si - Director of Cell Therapy Process Development, Bayer
12:30pm - 1:00pm
Enabling Rapid, High-Quality IND Filings for Cell and Gene Therapies: Platform Solutions for Plasmid and Viral Vector Manufacturing
  • Huiyi Zhu - Head of Hopewell Site Project Management Team, ProBio Inc
Showing 1 of 1 Streams
2:10pm - 2:15pm
Chairperson’s Opening Remarks: Cell Therapy Manufacturing & Analytics
  • Shashi Prajapati - Director, Cell & Gene Therapies Analytical Development, Vertex Pharmaceuticals
2:15pm - 2:45pm
Advanced Potency Assay Strategies for Cell Therapy Product Characterization
  • Lena Yang - Senior Scientist, Cell Therapy Analytical Development, Takeda
2:45pm - 3:15pm
Potency Assay for Commercial Product – Which One to Select?
  • Therese Choquette - Head of Analytical and Translational Sciences, Tigen Pharma
3:15pm - 3:45pm
Multilayered QC in CGT: From Vector Fidelity to Epigenetic Regulation
  • William Mauck - Team Lead Manager, Molecular Biology Lab, Solvias
Showing 1 of 1 Streams
4:30pm - 5:00pm
Best Practices for Developing Robust Potency Assays for Cell Therapies
  • Mariska ter Haak - Senior Director Analytical Development, IN8bio
5:00pm - 5:30pm
Analytical Development to Assess T Cell Therapy Product Potency: A Matrix Approach
  • Dong Xu, Ph.D. - Associate Director, TScan Therapeutics
Tuesday 16th September, 2025 - Workshop & Keynotes
NextThursday 18th September, 2025 - Main Conference Day Two
Filter
Streams
Clear
Choose Day